| NCT00256412 | University of Iowa | Major Depression | 2005-10 | NA |
| NCT03151291 | University of Erlangen-Nürnberg Medical School | Cancer|Cancer Cachexia|Weight Loss|Muscle Loss|Muscle Weakness | 2016-12 | NA |
| NCT00114595 | University of Stellenbosch|Stanley Medical Research Institute | Dyskinesia|Schizophrenia | 2003-04 | PHASE4 |
| NCT00014027 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Healthy | 2001-04-04 | PHASE1 |
| NCT01251887 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Weight Gain|Healthy Subjects|Obesity|Women | 2010-11-12 | NA |
| NCT07462013 | National Science and Technology Council, Taiwan|IRCCS Centro San Giovanni di Dio Fatebenefratelli|University College Cork | Major Depressive Disorder (MDD) | 2025-10-01 | NA |
| NCT06928701 | University of Eastern Piedmont | Early Breast Cancer|Neoadjuvant Treatment | 2024-09-01 | NA |
| NCT01369550 | Monsanto Company, LLC|Solae, LLC | Healthy Volunteers|Markers of Cardiovascular Risk | 2010-08 | NA |
| NCT00329680 | Fernandes Tavora Hospital|Abbott | Sepsis|Severe Sepsis|Septic Shock | 2007-06 | PHASE4 |
| NCT02069561 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Ulcerative Colitis | 2014-01 | NA |
| NCT02848469 | University College Cork | Psychotic Disorders | 2013-09 | PHASE2 |
| NCT04897893 | SCF Pharma|Integrated Health and Social Services Centres (CISSS) de la Gaspésie|Integrated Health and Social Services Centres (CISSS) du Bas-St-Laurent | Inflammation | 2021-04-21 | PHASE4 |
| NCT03806426 | S.L.A. Pharma AG | Familial Adenomatous Polyposis | 2018-12-05 | PHASE3 |
| NCT03972319 | Khoo Teck Puat Hospital | Fatty Liver|Bariatric Surgery Candidate | 2019-09-17 | EARLY_PHASE1 |
| NCT07461649 | Sichuan Credit Pharmaceutical Co., Ltd. | Bioavailability and Pharmacokinetics | 2026-03-15 | NA |
| NCT07439744 | National Science and Technology Council, Taiwan|Fondation FondaMental|Fondation pour la Recherche Médicale (FRM)|Ministry of Science and Technology, Taiwan | Obese Adults|MDD | 2025-03-01 | NA |
| NCT00455416 | Oslo University Hospital|University of Oslo | Follicular Lymphoma | 2007-04 | PHASE2 |
| NCT00361374 | Massachusetts General Hospital|Cedars-Sinai Medical Center|National Institute of Mental Health (NIMH) | Major Depressive Disorder | 2006-07 | PHASE3 |
| NCT01202812 | Thomas Jefferson University|Drexel University|GlaxoSmithKline | Sickle Cell Disease|HEMOGLOBIN SS|Hemoglobin S Beta-0 Thalassemia|Inflammation|Quality of Life | 2010-10 | PHASE2 |
| NCT00001146 | National Institute of Mental Health (NIMH) | Bipolar Disorder|Involutional Depression|Mood Disorder | 1999-10 | PHASE2 |
| NCT01070355 | University of Leeds | Colorectal Cancer | 2010-04 | PHASE2 |
| NCT03915535 | Samuel Fortin | Healthy Athletes | 2019-09-19 | PHASE4 |
| NCT00578578 | The Cleveland Clinic | Coronary Artery Disease|Inflammatory Response|Atherosclerosis | 2005-09 | PHASE4 |
| NCT00167310 | University of Pittsburgh|American Heart Association|VA Pittsburgh Healthcare System | Schizophrenia|Schizoaffective Disorder|Major Depression|Bipolar Disorder|Coronary Artery Disease | 2005-09 | PHASE2 |
| NCT04811404 | New York State Psychiatric Institute | Bipolar Disorder | 2021-03-19 | PHASE4 |
| NCT06695910 | Samuel Fortin|Institut de recherche clinique du littoral (IRCL) | Brain Fog|Cognitive Health | 2024-11-06 | PHASE4 |
| NCT03781557 | Sulaiman AlRajhi Colleges | Cognition|Brain|Neuroscience | 2019-01-01 | PHASE4 |
| NCT01308710 | University of California, San Francisco|Vanderbilt University|Tufts University|University of Guelph|University of L´Aquila | Hyperlipidemia | 2010-01 | PHASE1 |
| NCT00692718 | Osaka General Medical Center | Acute Heart Failure|Acute Myocardial Infarction | 2008-07 | PHASE4 |
| NCT00432913 | S.L.A. Pharma AG | Adenomatous Polyps | 2006-10 | PHASE2|PHASE3 |
| NCT04006847 | Milton S. Hershey Medical Center | Chronic Myeloid Leukemia, Chronic Phase | 2020-09-14 | PHASE1|PHASE2 |
| NCT06758778 | Sichuan Credit Pharmaceutical Co., Ltd.|Glogen Clinical Research Pvt. Ltd | Bioavailability | 2025-01-03 | NA |
| NCT00815685 | H. Lee Moffitt Cancer Center and Research Institute|GlaxoSmithKline | Cancer Cachexia | 2007-07 | NA |
| NCT02179372 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Ulcerative Colitis|Crohn´s Disease | 2014-06 | NA |
| NCT00398333 | Hospital Clinic of Barcelona|Abbott | Colorectal Neoplasms | 2005-06 | PHASE4 |
| NCT04335032 | S.L.A. Pharma AG | SARS-CoV-2 | 2021-01-08 | PHASE3 |
| NCT00839449 | Yamaguchi University Hospital|Nakamura Memorial Hospital|Iwate Medical University|Tohoku University|Ootemachi Hospital | Subarachnoid Hemorrhage|Cerebral Vasospasm | 2004-12 | PHASE4 |
| NCT00231738 | Kobe University|Mochida Pharmaceutical Company, Ltd. | Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease | 1996-11 | PHASE4 |
| NCT00031707 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|NCIC Clinical Trials Group | Anorexia|Cachexia | 2000-03 | PHASE3 |
| NCT00678067 | University of Milan | Hypercholesterolemia | 2005-06 | NA |
| NCT03143075 | Region Skane|University of California, San Francisco | Major Depressive Disorder | 2017-08-01 | NA |
| NCT02957188 | Université de Sherbrooke|Healthy Aging Research Network | Healthy Volunteers | 2015-08 | |
| NCT01270516 | Gerald Supinski | Muscle Weakness | 2014-01 | NA |
| NCT00621829 | University of California, Davis|National Institutes of Health (NIH) | Asthma | 2008-02 | NA |
| NCT01692431 | University of East Anglia | Cardiovascular Physiological Phenomena|Endothelial Nitric Oxide Synthase|Eicosapentaenoic Acid|Docosahexaenoic Acid (All-Z Isomer) | 2012-09 | NA |
| NCT06494488 | The Miriam Hospital|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI) | Lipid Metabolism Disorders|Hypertriglyceridemia | 2025-07-10 | EARLY_PHASE1 |
| NCT02615405 | National Science and Technology Council, Taiwan | Major Depressive Disorder | 2012-08 | NA |
| NCT01092377 | North-West University, South Africa|Swiss Federal Institute of Technology|Medical Research Council, South Africa|Unilever R&D | Iron Deficiency|Anemia | 2010-02 | NA |
| NCT02553915 | Massachusetts General Hospital|Emory University | Major Depressive Disorder|Overweight|Inflammation | 2015-12 | PHASE2|PHASE3 |
| NCT02670382 | Tufts University | Metabolic Syndrome | 2016-03 | NA |
| NCT02333435 | CHU de Quebec-Universite Laval | Prostate Cancer | 2015-02-12 | PHASE2 |
| NCT02715596 | Institut Català d´Oncologia|Ferrer Internacional S.A. | Squamous Cell Carcinoma of Head and Neck | 2015-12-23 | PHASE3 |
| NCT06975241 | University of Toronto | Healthy|Omega 3|Metabolism, Lipids | 2025-07-29 | PHASE4 |
| NCT01399216 | Hiroshima University|Three Peace Co., Ltd., Japan | Low Basal Body Temperature | 2011-07 | NA |
| NCT02498106 | Leiden University Medical Center|Atrium Innovations | Psychiatric Hospitalization | 2015-05 | NA |
| NCT04496154 | May Faraj, PDt, PhD|Canadian Institutes of Health Research (CIHR) | Type 2 Diabetes|Insulin Sensitivity+Resistance|Inflammatory Response|Fatty Acids, Omega-3 | 2013-09-05 | NA |
| NCT07289919 | University of Sao Paulo | Cardiovascular (CV) Risk|Atheroscleroses|Inflamation|Omega 3 Fatty Acids|Supplement | 2025-05-26 | NA |
| NCT04210804 | National University of Ireland, Galway, Ireland|Stanley Medical Research Institute | Bipolar Depression | 2014-04-01 | PHASE2 |
| NCT03378232 | University of Guelph|Ontario Ministry of Agriculture, Food and Rural Affairs | Cardiovascular Disease | 2017-01-05 | NA |
| NCT03657758 | Kobe University | Coronary Artery Disease|Angina Pectoris | 2018-09-17 | PHASE4 |
| NCT04972643 | Taichung Veterans General Hospital | Alzheimer Disease|Dementia Disorder | 2012-09-23 | NA |
| NCT00886704 | Ludwig-Maximilians - University of Munich | Atherosclerosis | 2009-04 | NA |
| NCT05438173 | Midwest Center for Metabolic and Cardiovascular Research|Naturmega | Bioavailability | 2022-07-11 | NA |
| NCT01038440 | Solae, LLC|Provident Clinical Research | Sudden Cardiac Death|Sudden Cardiac Arrest|Cardiovascular Disease | 2009-08 | NA |
| NCT01087710 | Abbott Nutrition | Asthma | 2004-07 | PHASE2 |
| NCT01896414 | University of Maryland, Baltimore|National Institutes of Health (NIH)|US Department of Veterans Affairs|National Heart, Lung, and Blood Institute (NHLBI) | Metabolic Syndrome | 2014-07 | NA |
| NCT01956188 | University of Sao Paulo | Systemic Lupus Erythematosus|Primary Antiphospholipid Syndrome | 2014-05 | NA |
| NCT01320319 | University of Nottingham|University Hospitals of Derby and Burton NHS Foundation Trust | Colorectal Cancer | 2011-03 | PHASE2|PHASE3 |
| NCT01138774 | Clinica Universidad de Navarra, Universidad de Navarra | Obesity|Body Fat|Insulin Resistance | 2010-01 | NA |
| NCT02705430 | Rabin Medical Center | Type 2 Diabetes | 2018-06-20 | NA |
| NCT01350999 | Takeda | Hypertriglyceridemia | 2009-11 | PHASE3 |
| NCT03708120 | ARCTEC | Tick Bites | 2018-11-15 | NA |
| NCT03443076 | Midwest Center for Metabolic and Cardiovascular Research|Pharmavite LLC | Bioavailability | 2018-02-16 | NA |
| NCT00290056 | Sheba Medical Center | Coronary Artery Disease|Arrhythmia | 2005-11 | PHASE4 |
| NCT00312455 | National Institute on Drug Abuse (NIDA) | Substance-related Disorders | 2004-07 | PHASE2 |
| NCT06731400 | University of Sao Paulo | Atherosclerosis Cardiovascular Disease | 2024-12-03 | NA |
| NCT00517036 | Cedars-Sinai Medical Center|National Institute of Mental Health (NIMH)|Massachusetts General Hospital | Depression | 2006-07 | PHASE3 |
| NCT02057406 | Wei Jiang|National Institute of Mental Health (NIMH) | Depression | 2014-05 | PHASE3 |
| NCT03258840 | Tehran University of Medical Sciences | Diabetes Mellitus Type II | 2013-01 | NA |
| NCT02661698 | Northumbria University|Pronova BioPharma | Lipid Absorption and Metabolism | 2016-02 | NA |
| NCT03499535 | Paul Windschitl | Lung Neoplasms|Radon Exposure|Smoking|Intention|Risk Reduction Behavior | 2015-08-07 | NA |
| NCT00988585 | Cardiovascular Research Associates|Dupont Applied Biosciences | Heart Disease | 2009-04 | PHASE1 |
| NCT01810003 | Laval University|Canadian Institutes of Health Research (CIHR) | Cardiovascular Disease, Inflammation | 2013-03 | NA |
| NCT02637778 | University of Jena|German Federal Ministry of Education and Research | Cardiovascular Diseases | 2016-02 | NA |
| NCT01749202 | Solae, LLC|Provident Clinical Research | Sudden Cardiac Death|Sudden Cardiac Arrest|Cardiovascular Disease | 2010-08 | NA |
| NCT01797757 | Société des Produits Nestlé (SPN) | Obesity | 2012-01 | NA |
| NCT06992323 | National Research Council, Spain|Beps Holding GmbH|Olivenova Health Sl | Hypertriglyceridemia|Normal | 2025-02-17 | NA |